Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Nucleoside/nucleotide reverse transcriptase inhibitor sparing regimen with once daily integrase inhibitor plus boosted darunavir is non-inferior to standard of care in virologically-suppressed children and adolescents living with HIV - Week 48 results of the randomised SMILE Penta-17-ANRS 152 clinical trial.
Compagnucci A, Chan MK, Saïdi Y, Cressey TR, Bamford A, Riault Y, Coelho A, Nolan A, Chalermpantmetagul S, Morkunaite G, Amuge P, Musiime V, Violari A, Cotton M, Kekitiinwa AR, Kaudha E, Groenewald M, Liberty AA, Kanjanavanit S, Volokha A, Bologna R, Pavia Ruz N, Prieto Tato L, Paioni P, Marques L, Reliquet V, Niehues T, Welch SB, Ford D, Giaquinto C, Gibb DM, Babiker A, Ramos Amador JT; SMILE-PENTA17-ANRS 152 Trial Group. Compagnucci A, et al. EClinicalMedicine. 2023 Jun 2;60:102025. doi: 10.1016/j.eclinm.2023.102025. eCollection 2023 Jun. EClinicalMedicine. 2023. PMID: 37304494 Free PMC article.
HIV-1 pretreatment drug resistance in vertically infected children is associated with poor virological response to protease inhibitor (PI)-based first-line antiretroviral therapy (ART): results from a cohort study in Argentina.
Rozenszajn M, Arazi-Caillaud S, Taicz M, Bologna R, Mangano A, Aulicino PC. Rozenszajn M, et al. Among authors: taicz m. J Antimicrob Chemother. 2022 Jun 29;77(7):1969-1973. doi: 10.1093/jac/dkac138. J Antimicrob Chemother. 2022. PMID: 35512329
[Epidemiological characteristics according to the progress of SARS-CoV-2 pandemic in a highly complex pediatric hospital in Argentina: a descriptive study].
Ferraro D, Arias AP, Pérez G, Gómez S, Deschutter V, Highton E, Taicz M, Trugman F, Picollo M, Bologna R, Rosanova MT. Ferraro D, et al. Among authors: taicz m. Rev Chilena Infectol. 2021 Aug;38(4):506-511. doi: 10.4067/S0716-10182021000400506. Rev Chilena Infectol. 2021. PMID: 34652396 Free article. Spanish.
Unraveling HIV-1 diagnosis in special pediatric cases.
Golemba MD, Mecikovsky D, Ortíz de Zárate M, Silva G, Aulicino PC, Pineda M, Taicz M, Rossi V, Bologna R, Mangano AM. Golemba MD, et al. Among authors: taicz m. J Clin Virol. 2020 Oct;131:104343. doi: 10.1016/j.jcv.2020.104343. Epub 2020 Apr 3. J Clin Virol. 2020. PMID: 32836174
Osteoarticular infections in a tertiary care children's hospital: Epidemiology and clinical characteristics in association with bacteremia.
Highton E, Pérez MG, Cedillo Villamagua C, Sormani MI, Mussini MS, Isasmendi A, Pinheiró J, Reijtman V, Taicz M, Mastroianni A, García ME, Rosanova MT. Highton E, et al. Among authors: taicz m. Arch Argent Pediatr. 2018 Apr 1;116(2):e204-e209. doi: 10.5546/aap.2018.eng.e204. Arch Argent Pediatr. 2018. PMID: 29557602 Free article. English, Spanish.
Risk factors for the appearance of secondary foci of infection in children with community-acquired Staphylococcus aureus bacteraemia. Cohort study 2010-2016.
Perez MG, Martiren S, Escarra F, Reijtman V, Mastroianni A, Varela-Baino A, Cedillo C, Garcia ME, Taicz M, Bologna R. Perez MG, et al. Among authors: taicz m. Enferm Infecc Microbiol Clin (Engl Ed). 2018 Oct;36(8):493-497. doi: 10.1016/j.eimc.2017.10.007. Epub 2017 Dec 6. Enferm Infecc Microbiol Clin (Engl Ed). 2018. PMID: 29217093 English, Spanish.
16 results